Hua Su Selected Research

DNA (Deoxyribonucleic Acid)

3/2022	Modified eQTL and Somatic DNA Segment Alterations in Esophageal Squamous Cell Carcinoma for Genes Related to Immunity, DNA Repair, and Inflammation.
11/2006	Genome-wide loss of heterozygosity and copy number alteration in esophageal squamous cell carcinoma using the Affymetrix GeneChip Mapping 10 K array.
9/2004	Comprehensive characterization of annexin I alterations in esophageal squamous cell carcinoma.
1/2003	Common genetic variants of TP53 and BRCA2 in esophageal cancer patients and healthy individuals from low and high risk areas of northern China.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hua Su Research Topics

Disease

35	Neoplasms (Cancer) 01/2024 - 07/2003
16	Arteriovenous Malformations (Arteriovenous Malformation) 01/2024 - 12/2008
14	Diabetic Nephropathies (Diabetic Nephropathy) 03/2024 - 11/2014
13	Inflammation (Inflammations) 02/2024 - 07/2012
12	Hemorrhage 02/2024 - 07/2011
11	Stroke (Strokes) 01/2021 - 04/2010
10	Fibrosis (Cirrhosis) 11/2023 - 09/2009
10	Esophageal Squamous Cell Carcinoma 10/2022 - 01/2003
9	Proteinuria 05/2024 - 01/2015
9	Hypoxia (Hypoxemia) 01/2020 - 07/2002
8	Infarction (Infarctions) 01/2021 - 11/2004
8	Hereditary Hemorrhagic Telangiectasia 01/2020 - 12/2008
7	Ischemic Stroke 04/2024 - 01/2013
7	Acute Kidney Injury (Acute Renal Failure) 01/2023 - 01/2017
6	Lung Neoplasms (Lung Cancer) 01/2022 - 10/2009
6	Adenocarcinoma 01/2021 - 10/2011
6	COVID-19 01/2021 - 01/2020
5	Ischemia 01/2023 - 01/2003
4	Wounds and Injuries (Trauma) 04/2024 - 03/2013
4	Carcinogenesis 10/2022 - 06/2008
4	Neoplasm Metastasis (Metastasis) 10/2022 - 01/2021
4	Kidney Diseases (Kidney Disease) 01/2022 - 01/2017
4	Rupture 01/2022 - 03/2009
4	Atrophy 01/2021 - 04/2010
4	Infections 01/2021 - 11/2004
4	Starvation 01/2021 - 04/2014
4	Pulmonary Hypertension 01/2020 - 03/2016
4	Chronic Renal Insufficiency 01/2020 - 01/2017
4	Type 2 Diabetes Mellitus (MODY) 01/2019 - 10/2008
4	Bone Fractures (Bone Fracture) 12/2017 - 06/2013
4	Stomach Neoplasms (Stomach Cancer) 02/2016 - 01/2013
4	Brain Injuries (Brain Injury) 11/2014 - 10/2006
3	Albuminuria 03/2024 - 01/2015
3	Vascular Remodeling 06/2023 - 07/2009
3	Obesity 01/2022 - 10/2008
3	Vascular Malformations 01/2022 - 07/2012
3	Hypertension (High Blood Pressure) 01/2022 - 01/2018
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2019 - 01/2015
3	Hyperglycemia 01/2017 - 01/2015
3	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2017 - 11/2011
3	Myocardial Infarction 01/2012 - 09/2009
2	Paraproteinemias (Monoclonal Gammopathy) 05/2024 - 01/2019
2	Pulmonary Arterial Hypertension 06/2023 - 12/2018
2	Liver Diseases (Liver Disease) 10/2022 - 12/2021
2	Encephalitis (Encephalitis, Rasmussen) 08/2022 - 10/2012
2	Sepsis (Septicemia) 05/2022 - 01/2014
2	Adenocarcinoma of Lung 01/2022 - 01/2021
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 01/2013

Drug/Important Bio-Agent (IBA)

25	Proteins (Proteins, Gene)FDA Link 04/2024 - 04/2003
15	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2019 - 07/2002
11	EndoglinIBA 02/2024 - 07/2009
9	RNA (Ribonucleic Acid)IBA 02/2024 - 09/2004
9	Activin Receptors (Activin Receptor)IBA 01/2024 - 12/2008
9	Messenger RNA (mRNA)IBA 10/2022 - 09/2004
9	CytokinesIBA 10/2022 - 09/2004
8	Biomarkers (Surrogate Marker)IBA 04/2024 - 06/2008
8	LipidsIBA 03/2024 - 01/2018
6	MicroRNAs (MicroRNA)IBA 10/2022 - 08/2015
5	CollagenIBA 01/2024 - 01/2021
5	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2021 - 01/2014
5	InflammasomesIBA 01/2021 - 11/2014
4	CreatinineIBA 05/2024 - 01/2019
4	EnzymesIBA 03/2024 - 09/2012
4	Phosphotransferases (Kinase)IBA 02/2024 - 09/2010
4	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2023 - 01/2015
4	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 06/2016
4	DNA (Deoxyribonucleic Acid)IBA 03/2022 - 01/2003
4	Interleukin-6 (Interleukin 6)IBA 02/2019 - 03/2009
4	cresyl violetIBA 02/2019 - 10/2006
3	AntigensIBA 05/2024 - 12/2002
3	Activins (Activin)IBA 02/2024 - 09/2010
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2024 - 01/2015
3	IronIBA 01/2024 - 01/2014
3	Long Noncoding RNAIBA 01/2023 - 03/2016
3	Matrix Metalloproteinases (MMPs)IBA 10/2022 - 07/2009
3	VaccinesIBA 08/2022 - 03/2009
3	Neutralizing AntibodiesIBA 08/2022 - 10/2012
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 12/2015
3	Claudin-5IBA 11/2020 - 12/2017
3	ErbB Receptors (EGF Receptor)IBA 01/2017 - 11/2009
3	Vitamin D FDA LinkGeneric 02/2016 - 09/2012
3	ThioredoxinsIBA 01/2016 - 11/2014
3	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2016 - 01/2015
3	PolyethyleneimineIBA 01/2015 - 01/2013
3	Small Interfering RNA (siRNA)IBA 01/2015 - 01/2013
2	Sirtuin 1IBA 04/2024 - 12/2015
2	Macrophage Colony-Stimulating FactorIBA 02/2024 - 05/2023
2	IntegrinsIBA 11/2023 - 12/2016
2	Cadherins (E-Cadherin)IBA 10/2023 - 01/2021
2	Circular RNAIBA 06/2023 - 01/2020
2	MonocrotalineIBA 06/2023 - 12/2018
2	Sirtuin 3IBA 01/2023 - 04/2018
2	Complement System Proteins (Complement)IBA 10/2022 - 01/2022
2	Ethanol (Ethyl Alcohol)IBA 09/2022 - 12/2021
2	6-methyladenineIBA 01/2022 - 01/2020

Therapy/Procedure

27	Therapeutics 01/2024 - 10/2006
3	Punctures 06/2022 - 07/2019
3	Drug Therapy (Chemotherapy) 01/2021 - 01/2015
3	Renal Dialysis (Hemodialysis) 10/2020 - 01/2018
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 04/2023 - 01/2010